September 2009 Entitlement Issue Prospectus


18th September 2009
Entitlement Issue Prospectus

Disclaimer
Note for intended users of this Prospectus:

A Prospectus dated 18 September 2009 issued by Anteo Diagnostics Limited ABN 75 070 028 625 (“Company”) for a fully underwritten pro rata non-renounceable entitlement issue of 1 Share for every 1 Share held by Shareholders at an issue price of 0.6 cents per Share, together with 1 Attaching Option (for no additional consideration) for every 1 Share subscribed for, to raise up to approximately $1,080,659.

The closing date of the Prospectus is 20 October 2009.

IMPORTANT INFORMATION

Persons who access the Prospectus in electronic form should note that the securities offered by this Prospectus should be considered speculative. Before deciding to invest in the Company potential investors should read the entire Prospectus and in particular consider the risk factors that could affect the financial performance of the Company. You should carefully consider these risks in light of your personal circumstances (including financial and taxation issues) and seek professional advice from your accountant, stockbroker, lawyer or other professional adviser before deciding whether to invest.

The securities to which the Prospectus relates will only be issued on receipt of an Application Form issued together with the Prospectus.

The offer to which the Prospectus relates is available to persons receiving electronic disclosure documents in Australia. Users of the Application Form included in the Prospectus should note:

  i. the Prospectus contains information regarding investing in the securities referred to in the Application Form;
  ii. potential investors are strongly advised to read the Prospectus before applying for securities; and
  iii. a person who gives another person access to the Application Form must at the same time and by the same means give the other person access to the Prospectus and any supplementary document.

Lodgement of Prospectus with ASIC

The paper form of the electronic Prospectus accessible through this website has been lodged with the Australian Securities and Investments Commission (ASIC).

Warning

For legal reasons, the information and electronic Prospectus provided by this website is available to persons accessing this website from within AUSTRALIA ONLY.

This Prospectus does not constitute an offer of securities in any jurisdiction where, or to any person to whom, it would not be lawful to issue the Prospectus or make the offer. It is the responsibility of any Applicant outside Australia to ensure compliance with all laws of any country relevant to their Applications, and any such Applicant should consult their professional advisers as to whether any government or other consents are required, or whether any formalities need to be observed to enable them to apply for and be allotted any securities.

No action has been taken to register or qualify the Shares or the Offer or otherwise to permit an offering of the Shares in any jurisdiction outside Australia.

Whilst the Prospectus is current, the Company will send copies of the Prospectus and any supplementary document and the Application Form, on request and without charge within a reasonable time after the request is received. In this regard, please contact:

Mr Shane Hartwig
Company Secretary
Anteo Diagnostics Limited
Level 5, 56 Pitt Street
Sydney
Telephone: (02) 8823 3100
Facsimile: (02) 9252 8466
Email: shartwig@transoceangroup.com

Download Prospectus

To download the prospectus, you must read and acknowledge the above information.

I have read and understood the above information

Terms of Access, Privacy, © 2008 Anteo diagnostics Website by JOiE Creative